Cardiac toxicity is a major concern in drug development and it is imperative that clinical candidates are thoroughly tested for adverse effects earlier in the drug discovery process. In a new research study (1), Abassi et al. investigated the use of Roche-s (SIX: RO, ROG; OTCQX: RHHBY) xCELLigence Cardio Instrument in conjunction with embryonic stem cell derived cardiomyocytes (ESCC) for assessment of compound risk in the drug discovery process. The xCELLigence Cardio Instrument is an impedance
DAILY RFID has recently developed UHF Metal Tag-05, which is designed to mount on metal for tracking usage. In spite of the metal weakening effect on read range, this kind of metal mount RFID tag combines small footprint and stable detecting performance in metallic environment.
MORGES, SWITZERLAND — (Marketwire) — 09/13/11 — Omnisens, a leader in continuous, systems for pipelines, has received substantial investment from SVC Ltd., an investment vehicle fully owned by Credit Suisse.-Given their success in the most demanding projects from Alaska to the Andes, it was clear that Omnisens provide a much needed solution to help ensure the safe and efficient transport of oil and gas- said Andreas Koopmann, Chairman of the Investment Committee of SVC.Examples of the asset
MORGES, SWITZERLAND — (Marketwire) — 09/13/11 — , a pioneer in continuous, long distance monitoring systems for energy cables, has received substantial investment from SVC Ltd., an investment vehicle fully owned by Credit Suisse."From their success in projects demanding cost-efficient, long distance, accurate monitoring, the Omnisens systems are clearly answering a market need," said Andreas Koopmann, chairman of the Investment Committee of SVC. The systems are considered accurate
FREMONT, CA — (Marketwire) — 09/09/11 — Mattson Technology, Inc. (NASDAQ: MTSN), a leading supplier of advanced process equipment used to manufacture semiconductors, today announced that that the Company is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference, being held September 11-13, 2011 at the Waldorf Astoria Hotel, 301 Park Ave, New York. David Dutton, president and chief executive officer, and Andrew Moring, chief financial officer, will present in a g
